Page last updated: 2024-08-24

1h-imidazo(4,5-b)pyridine and Diabetes Mellitus, Type 2

1h-imidazo(4,5-b)pyridine has been researched along with Diabetes Mellitus, Type 2 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ali, S; Imran, S; Ismail, NH; Jamil, W; Kashif, SM; Khan, KM; Rahim, F; Rashwan, H; Salar, U; Taha, M	1

Other Studies

1 other study(ies) available for 1h-imidazo(4,5-b)pyridine and Diabetes Mellitus, Type 2

Article	Year
Synthesis of 6-chloro-2-Aryl-1H-imidazo[4,5-b]pyridine derivatives: Antidiabetic, antioxidant, β-glucuronidase inhibiton and their molecular docking studies. Bioorganic chemistry, 2016, Volume: 65 Topics: Antioxidants; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Glucuronidase; Glycoproteins; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Molecular Structure; Purines; Structure-Activity Relationship	2016

Article

Year

Synthesis of 6-chloro-2-Aryl-1H-imidazo[4,5-b]pyridine derivatives: Antidiabetic, antioxidant, β-glucuronidase inhibiton and their molecular docking studies.

Bioorganic chemistry, 2016, Volume: 65

Topics: Antioxidants; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Glucuronidase; Glycoproteins; Humans; Hypoglycemic Agents; Molecular Docking Simulation; Molecular Structure; Purines; Structure-Activity Relationship

2016